Medigen Vaccine Biologics Corp. is partnering with an American biotech company to develop a COVID-19 vaccine patch, which could begin human clinical trials as early as in 2022, the Taiwanese vaccine maker announced Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
- Business
Late tycoon's heirs ordered to pay damages over Kuo Hua Life bailout
11/21/2024 09:26 PM - Society
Court orders murderer of Malaysian student to pay family compensation
11/21/2024 08:57 PM - Politics
More U.S. state offices in Taiwan signify closer ties: Official
11/21/2024 08:44 PM - Society
Lows of 14 degrees forecast for northern Taiwan next week
11/21/2024 08:31 PM